Cargando…

Decorin: A Growth Factor Antagonist for Tumor Growth Inhibition

Decorin (DCN) is the best characterized member of the extracellular small leucine-rich proteoglycan family present in connective tissues, typically in association with or “decorating” collagen fibrils. It has substantial interest to clinical medicine owing to its antifibrotic, anti-inflammatory, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Järvinen, Tero A. H., Prince, Stuart
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677162/ https://www.ncbi.nlm.nih.gov/pubmed/26697491 http://dx.doi.org/10.1155/2015/654765

Ejemplares similares

Decorin is a novel antagonistic ligand of the Met receptor
por: Goldoni, Silvia, et al.
Publicado: (2009)

Decorin—An Antagonist of TGF-β in Astrocytes of the Optic Nerve
por: Schneider, Magdalena, et al.
Publicado: (2021)

Systemically Administered Homing Peptide Targets Dystrophic Lesions and Delivers Transforming Growth Factor-β (TGFβ) Inhibitor to Attenuate Murine Muscular Dystrophy Pathology
por: Iqbal, Aqsa, et al.
Publicado: (2021)

Oncosuppressive functions of decorin
por: Neill, Thomas, et al.
Publicado: (2015)

Systemically Administered, Target Organ-Specific Therapies for Regenerative Medicine
por: Järvinen, Tero A. H., et al.
Publicado: (2015)

Decorin inhibits the insulin-like growth factor I signaling in bone marrow mesenchymal stem cells of aged humans
por: Wong, Tze-Hong, et al.
Publicado: (2020)

Biological functions of decorin in cancer
por: Bi, Xiu-Li, et al.
Publicado: (2013)

The Role of Decorin Proteoglycan in Mitophagy
por: Neill, Thomas, et al.
Publicado: (2022)

Decreased decorin expression in the tumor microenvironment
por: Bozoky, Benedek, et al.
Publicado: (2014)

ANTAGONISTIC GROWTH-ACTIVATING AND GROWTH-INHIBITING PRINCIPLES IN SERUM
por: Carrel, Alexis, et al.
Publicado: (1923)

Granzyme B Cleaves Decorin, Biglycan and Soluble Betaglycan, Releasing Active Transforming Growth Factor-β1
por: Boivin, Wendy A., et al.
Publicado: (2012)

Role of Decorin in the Lens and Ocular Diseases
por: Kubo, Eri, et al.
Publicado: (2022)

The Role of Decorin in Autoimmune and Inflammatory Diseases
por: Dong, Yuanji, et al.
Publicado: (2022)

Recombinant Decorin Fusion Protein Attenuates Murine Abdominal Aortic Aneurysm Formation and Rupture
por: Shen, Yue, et al.
Publicado: (2017)

Decorin Mimic Regulates Platelet-Derived Growth Factor and Interferon-γ Stimulation of Vascular Smooth Muscle Cells
por: Scott, Rebecca A., et al.
Publicado: (2014)

Neointimal hyperplasia after carotid transection and anastomosis surgery is associated with degradation of decorin and platelet-derived growth factor signaling
por: D'Cruz, Roshan J., et al.
Publicado: (2020)

Decorin treatment of spinal cord injury
por: Esmaeili, Maryam, et al.
Publicado: (2014)

Decorin as a possible strategy for the amelioration of COVID-19
por: Allawadhi, Prince, et al.
Publicado: (2021)

Decorin Mimic Inhibits Vascular Smooth Muscle Proliferation and Migration
por: Scott, Rebecca A., et al.
Publicado: (2013)

Correction: Granzyme B Cleaves Decorin, Biglycan and Soluble Betaglycan, Releasing Active Transforming Growth Factor-β1
por: Boivin, Wendy A., et al.
Publicado: (2012)

Asthma reduces glioma formation by T cell decorin-mediated inhibition of microglia
por: Chatterjee, Jit, et al.
Publicado: (2021)

Therapeutic potential of growth factors and their antagonists.
por: Garner, A.
Publicado: (1992)

Decorin is a pivotal effector in the extracellular matrix and tumour microenvironment
por: Zhang, Wen, et al.
Publicado: (2018)

T-cell-expressed proprotein convertase FURIN inhibits DMBA/TPA-induced skin cancer development
por: Vähätupa, Maria, et al.
Publicado: (2016)

Elucidating Decorin’s role in the preovulatory follicle
por: Kedem, A., et al.
Publicado: (2020)

Human Metaplastic Breast Carcinoma and Decorin
por: Boström, Pia, et al.
Publicado: (2017)

Decorin Inhibits Dermal Mesenchymal Cell Migration and Induces Scar Formation
por: Takaya, Kento, et al.
Publicado: (2022)

The Role of Decorin and Biglycan Signaling in Tumorigenesis
por: Diehl, Valentina, et al.
Publicado: (2021)

Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model
por: YIN, TAO, et al.
Publicado: (2015)

Decorin: a multifunctional proteoglycan involved in oocyte maturation and trophoblast migration
por: Park, Beom Seok, et al.
Publicado: (2021)

Cashmere growth control in Liaoning cashmere goat by ovarian carcinoma immunoreactive antigen-like protein 2 and decorin genes
por: Jin, Mei, et al.
Publicado: (2018)

Decorin has Met a new receptor
por: Short, Ben
Publicado: (2009)

Novel Antagonists of Heparin Binding Growth Factors
por: Cecchi, Fabiola, et al.
Publicado: (2012)

An essential role for decorin in bladder cancer invasiveness
por: El Behi, Mohamed, et al.
Publicado: (2013)

Differential inhibition of postnatal brain, spinal cord and body growth by a growth hormone antagonist
por: McIlwain, DL, et al.
Publicado: (2004)

Stromal Expression of Decorin, Semaphorin6D, SPARC, Sprouty1 and Tsukushi in Developing Prostate and Decreased Levels of Decorin in Prostate Cancer
por: Henke, Alexander, et al.
Publicado: (2012)

CysLT(1)R Antagonists Inhibit Tumor Growth in a Xenograft Model of Colon Cancer
por: Savari, Sayeh, et al.
Publicado: (2013)

Decorin inhibits proliferation and metastasis in human bladder cancer cells by upregulating P21
por: Chen, Hongjie, et al.
Publicado: (2022)

A Peptide Antagonist of the ErbB1 Receptor Inhibits Receptor Activation, Tumor Cell Growth and Migration In Vitro and Xenograft Tumor Growth In Vivo
por: Xu, Ruodan, et al.
Publicado: (2010)

A Fibroblast Growth Factor Antagonist Peptide Inhibits Breast Cancer in BALB/c Mice
por: Jafarzadeh, Mehrzad, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e22ia6t150627n0ao1u3r56qpr